Search
Theravance Biopharma Inc
TBPHAdd to Watchlist
16.930USD
-0.050-0.29%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
872.15MMarket Cap
7.42P/E TTM
Theravance Biopharma Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
107.46M
66.92%
EPS(YoY)
2.10
282.21%
Analyst Rating
HOLD
2026-07-02
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its total revenue reached 107.46M, with a year-on-year change of 66.92.
What are the current assets of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its current assets were 418.46M, with a year-on-year change of 159.80.
What are the total assets of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its total assets of Theravance Biopharma Inc were 485.57M, with a year-on-year change of 37.10.
What are the total liabilities of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its total liabilities of Theravance Biopharma Inc were 188.85M, with a year-on-year change of 5.73.
What is the total equity of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its total equity of Theravance Biopharma Inc was 296.72M, with a year-on-year change of 69.03.
What is the net investment of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its net investment of Theravance Biopharma Inc was -105.28M, with a year-on-year change of -957.08.
What is the net financing of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its net financing of Theravance Biopharma Inc was -3.25M, with a year-on-year change of -30.08.
What is the Earnings Per Share (EPS) of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 2.10, with a year-on-year change of 282.21.
What is the net margin of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its net profit margin was 98.54, with a year-on-year change of 212.45.
What is the debt-to-asset ratio of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its debt-to-asset ratio was 6.75, with a year-on-year change of -21.15.
What is the Return on Equity (ROE) of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was 44.85, with a year-on-year change of 254.42.
What is the Return on Assets (ROA) of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was 25.22, with a year-on-year change of 264.55.
What is the operating profit of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its operating profit was -3.60M, with a year-on-year change of 91.51.